BOL Pharma, an Israel-based medical cannabis company, announced last week it completed its first shipment of medical marijuana to medical centers that specialize in treating children with epilepsy and autism in the U.K.
BOL Pharma says it's the only Israeli company to comply with international regulations and the first to obtain approval for exporting medical cannabis products, manufactured under strict EU-GMP conditions. The company intends to expand its shipments and supply its unique products to further destinations in the near future, management told Benzinga.
The current shipment follows the change led by the Israeli government in its resolution from January, enabling BOL Pharma to operate as a leading exporter of cannabis and its derivatives.
“These are exciting times which symbolize a true breakthrough for the Israeli medical cannabis market,” said Hagai Hillman, BOL Pharma’s founder.
He added Israel is at the forefront of the life science industry throughout the western world in terms of regulation, research and product development, and quoted BOL Pharma’s ongoing “advanced clinical studies for various indications, including pain syndromes, oncology, orthopedics, neurology, gynecology, autism and pediatric diseases. Harnessing the developing exports will allow us to continue benefiting children and severely ill patients around the world."
Hagai Hillman, BOL Pharma’s founder. Courtesy of BOL Pharma.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.